Company intelligence / Profile preview
Open Source Therapeutics
Suzhou, Jiangsu, Chinaopensrcbio.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Open Source Therapeutics (also known as Shengruizehua Pharmaceutical Technology) is an innovative biotechnology company founded in 2022 by Dr. Lisheng Deng. The company is driven by artificial intelligence (AI) and automation to discover and develop novel small molecule therapeutics and molecular glues. Utilizing its proprietary TangramChem platform, Open Source Therapeutics focuses on oncology, inflammatory, and metabolic diseases. Its lead program, OST11098, is a selective CYP11A1 inhibitor that recently received FDA IND clearance for the treatment of castration-resistant prostate cancer (CRPC). The company's pipeline also includes OST08267, a PDE3A-SLFN12 molecular glue for gastrointestinal stromal tumors, and a PDE4B inhibitor partnered with Pharmacin for idiopathic pulmonary fibrosis.
- Therapeutic areas
- OncologyRheumatologyNeurologyPulmonology
- Modalities
- Small moleculeMolecular glue therapy
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Pharmacin
Beyond the preview
Go deeper on Open Source Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Open Source Therapeutics.